The CA9 levels did not significantly vary in patients with the indicated etiologies of liver disease (p = 0.403, p = 0.767 and p = 0.438, for HBV, HCV infection or NASH, respectively). This evidence concerns the gene CA9 and metabolic dysfunction-associated steatohepatitis.